default author photo

Yiming Shao

National Center for AIDS/STD Control and Prevention (NCAIDS) - Division of Virology and Immunology

Beijing

China

Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID)

China

SCHOLARLY PAPERS

3

DOWNLOADS

125

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Development and Validation of a Prognostic Model for Long-Term Survival after Starting Antiretroviral Therapy: A 15-Year Retrospective Cohort Study in Southwest China

Number of pages: 22 Posted: 12 Nov 2020
Guangxi Medical University, Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Guangxi Center for Disease Prevention and Control, University of Kentucky - School of Public Health, Guangxi Center for Disease Prevention and Control, Guangxi Medical University - Guangxi Key Laboratory of AIDS Prevention and Treatment and National Center for AIDS/STD Control and Prevention (NCAIDS) - Division of Virology and Immunology
Downloads 55 (1,010,164)

Abstract:

Loading...

prognostic model, HIV, High Active Antiretroviral Therapy, overall survival.

2.

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: A Multicenter Observational Study

Number of pages: 24 Posted: 12 Jul 2023
Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), University of Texas at San Antonio - Department of Public Health, National Center for AIDS/STD Control and Prevention (NCAIDS) - Division of Virology and Immunology, National Center for AIDS/STD Control and Prevention (NCAIDS) - Division of Virology and Immunology and National Center for AIDS/STD Control and Prevention (NCAIDS) - Division of Virology and Immunology
Downloads 38 (1,209,354)

Abstract:

Loading...

HIV, mutation, pretreatment drug resistance, risk factors, molecular transmission network

3.

HIV CRF07_BC is Independently Associated With Slower Disease Progression Than Subtype B in Chinese Patients: A Retrospective Observational Cohort Study

Number of pages: 40 Posted: 24 Mar 2021
Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, National Center for AIDS/STD Control and Prevention (NCAIDS) - Division of Virology and Immunology, Capital Medical University - Clinical and Research Center of Infectious Diseases, Capital Medical University - Center for Infectious Diseases, Peking Union Medical College Hospital - Department of Infectious Disease, 302 Military Hospital of China - Treatment and Research Center for Infectious Diseases, Chinese Center for Disease Control and Prevention (China CDC) - State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS) - Division of Virology and Immunology, Tianjin CDC - Institute for HIV/AIDS and STD Prevention and Control, Hebei CDC - Institute for HIV/AIDS and STD Prevention and Control, Shanxi CDC - Institute for HIV/AIDS and STD Prevention and Control, Inner Mongolia CDC - Institute for HIV/AIDS and STD Prevention and Control, Jilin CDC - Institute for HIV/AIDS and STD Prevention and Control, Shanghai CDC - Institute for HIV/AIDS and STD Prevention and Control, Anhui CDC - Institute for HIV/AIDS and STD Prevention and Control, Fujian CDC - Institute for HIV/AIDS and STD Prevention and Control, Jianxi CDC - Institute for HIV/AIDS and STD Prevention and Control, Shandong CDC - Institute for HIV/AIDS and STD Prevention and Control, Hunan CDC - Institute for HIV/AIDS and STD Prevention and Control, Guangdong CDC - Institute for HIV/AIDS and STD Prevention and Control, Guangxi CDC - Institute for HIV/AIDS and STD Prevention and Control, Chongqing CDC - Institute for HIV/AIDS and STD Prevention and Control, Sichuan CDC - Institute for HIV/AIDS and STD Prevention and Control, Gansu CDC - Institute for HIV/AIDS and STD Prevention and Control, Beijing Red Cross Blood Center, Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, Government of the People's Republic of China - Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control, 302 Military Hospital of China - Treatment and Research Center for Infectious Diseases, Capital Medical University - Clinical and Research Center for Infectious Diseases, National Center for AIDS/STD Control and Prevention (NCAIDS) - Division of Virology and Immunology and Beijing Center for Disease Prevention and Control (CDC) - Institute for HIV/AIDS and STD Prevention and Control
Downloads 32 (1,290,922)

Abstract:

Loading...